A class of anti-inflammatory drug used to relieve pain due to inflammation have been linked to an increased risk of death from stroke, according to a new study published online in the journal Neurology. Cyclooygenase-2 (COX-2) inhibitors are a form of non-steroidal anti-inflammatory drugs (NSAIDS) that directly target COX-2, an enzyme responsible for inflammation and pain. They are often used to treat pain after surgery as well as arthritis pain, menstrual cramps, and pain from noncancerous colon polyps. Currently marketed drugs in this class include the brand names Bextra (valdecoxib) and Celebrex (celecoxib), and also include the painkiller Vioxx (rofecoxib), which ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.